NN Investment Partners Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$130M Buy
454,808
+6,731
+2% +$1.73M 0.7% 28
2021
Q4
$124M Buy
448,077
+40,582
+10% +$10.3M 0.62% 37
2021
Q3
$94.2M Buy
407,495
+218,660
+116% +$54M 0.52% 40
2021
Q2
$43.3M Sell
188,835
-64,905
-26% -$13M 0.23% 80
2021
Q1
$47.4M Sell
253,740
-191,763
-43% -$37.5M 0.28% 68
2020
Q4
$75.2M Sell
445,503
-239,652
-35% -$35.8M 0.46% 46
2020
Q3
$101M Sell
685,155
-52,229
-7% -$8.08M 0.66% 29
2020
Q2
$121M Buy
737,384
+2,594
+0.4% +$398K 0.81% 25
2020
Q1
$102M Buy
734,790
+353,052
+92% +$48.5M 0.83% 28
2019
Q4
$50.2M Buy
381,738
+30,888
+9% +$3.58M 0.34% 62
2019
Q3
$39.2M Buy
350,850
+19,845
+6% +$2.21M 0.31% 74
2019
Q2
$36.7M Sell
331,005
-17,968
-5% -$2.12M 0.29% 76
2019
Q1
$45.3M Sell
348,973
-155,812
-31% -$18.9M 0.35% 65
2018
Q4
$58.4M Sell
504,785
-289,957
-36% -$32.4M 0.49% 46
2018
Q3
$85.3M Sell
794,742
-90,820
-10% -$9.08M 0.61% 37
2018
Q2
$75.6M Sell
885,562
-201,799
-19% -$16.6M 0.55% 43
2018
Q1
$84.1M Sell
1,087,361
-522,636
-32% -$42.1M 0.6% 41
2017
Q4
$136M Buy
1,609,997
+444,628
+38% +$37.8M 0.96% 24
2017
Q3
$99.7M Buy
1,165,369
+232,067
+25% +$19M 0.63% 40
2017
Q2
$76.8M Sell
933,302
-253,547
-21% -$20.7M 0.71% 39
2017
Q1
$99.8M Buy
1,186,849
+104,626
+10% +$8.38M 0.95% 23
2016
Q4
$79.6M Buy
1,082,223
+64,563
+6% +$4.81M 0.75% 36
2016
Q3
$81.7M Sell
1,017,660
-48,945
-5% -$3.92M 0.77% 36
2016
Q2
$84M Buy
1,066,605
+215,606
+25% +$16.2M 0.79% 34
2016
Q1
$61.3M Buy
+850,999
New +$64.4M 0.59% 50

Other funds holding LLY

NN Investment Partners Holdings's LLY Position: Q1 2022 in Review

NN Investment Partners Holdings increased its Eli Lilly (LLY) stake by 1.5% in Q1 2022, buying an estimated $1.73M and bringing the position to 454,808 shares worth $130M. The position accounts for 0.7% of the portfolio, ranked #28.

NN Investment Partners Holdings first reported a position in LLY in Q1 2016 and has held it in 25 quarters since. The position peaked at $136M in Q4 2017. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • NN Investment Partners Holdings held 454,808 shares of Eli Lilly worth $130M as of Q1 2022.
  • NN Investment Partners Holdings bought 6,731 Eli Lilly shares in Q1 2022, an estimated $1.73M.
  • Eli Lilly made up 0.7% of NN Investment Partners Holdings's portfolio in Q1 2022, its #28 holding.
  • NN Investment Partners Holdings first reported a position in Eli Lilly in Q1 2016 and has held it in 25 quarters since.
  • NN Investment Partners Holdings's Eli Lilly position peaked at $136M in Q4 2017.
  • 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.